We provide a comprehensive solution for the early detection of cancer by leveraging artificial intelligence, machine learning, and advanced radiomics and multiomics technologies. Our approach has demonstrated up to 93% accuracy in the early detection and classification of cancer.
Headquartered in Chicago, with offices worldwide
Major customers include leading pharmaceutical companies, research organizations, and healthcare systems
Winner of the Digital Biomarker category at the 2021 Innovation Leaders Summit in Tokyo, Japan
We believe that the key to defeating cancer lies in understanding it from every angle. Our team of world-class researchers is dedicated to unraveling the complexities of cancer at the molecular level. Through cutting-edge genomic studies, we are identifying new targets for treatment and uncovering the mechanisms that drive cancer progression.
“Cancer treatment is too painful, too expensive, and too ineffective because the focus of care is on the end—not the beginning—of the disease.”
Syed Alam
Founder & CEO, accentedge Health
Our mission is to revolutionize the fight against cancer. In a world where cancer remains one of the leading causes of death globally, we stand on the front line—armed with innovation, technology, and compassion.
Our vision is bold yet simple: a future where cancer no longer claims lives.
